#BEGIN_DRUGCARD DB03793

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
65-85-0

# ChEBI_ID:
30746

# Chemical_Formula:
C7H6O2

# Chemical_IUPAC_Name:
benzoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Food Preservatives

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
1.87

# Experimental_Logs:
-1.55

# Experimental_Water_Solubility:
3400 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Benzoic Acid

# HET_ID:
BEZ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)

# InChI_Key:
InChIKey=WPYMKLBDIGXBTP-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00180

# KEGG_Drug_ID:
D00038

# LIMS_Drug_ID:
3793

# Mechanism_Of_Action:
Not Available

# Melting_Point:
122.4 °C

# Molecular_Weight_Avg:
122.1213

# Molecular_Weight_Mono:
122.036779436

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1ONI

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA448578

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.72

# Predicted_LogS:
-1.2

# Predicted_Water_Solubility:
7.08e+00 g/l

# Primary_Accession_No:
DB03793

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
243

# PubChem_Substance_ID:
46504911

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00675

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=CC=CC=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-20 17:28:20 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
4.19 (at 25 °C)

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
M63808

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
nfnB

# Drug_Target_10_Gene_Sequence:
>654 bp
ATGGATATCATTTCTGTCGCCCTGAAACGCCACTCTACCAAGGCGTTCGACGCAAGCAAA
AAACTGACCGCGGAAGAAGCGGAAAAAATCAAAACCCTGCTGCAGTACAGCCCGTCCAGC
ACCAACTCCCAGCCGTGGCACTTCATTGTAGCCAGCACCGAGGAAGGAAAAGCGCGCGTG
GCGAAGTCCGCTGCGGGCACCTATGTGTTCAACGAACGCAAAATGCTGGATGCTTCCCAC
GTGGTGGTGTTCTGCGCGAAAACCGCGATGGATGACGCCTGGCTGGAGCGCGTCGTGGAT
CAGGAAGAGGCCGATGGCCGTTTCAACACGCCGGAAGCCAAAGCCGCAAACCATAAGGGC
CGCACCTACTTCGCCGACATGCACCGCGTGGATCTGAAAGATGACGACCAGTGGATGGCG
AAGCAGGTTTACCTGAACGTCGGCAACTTCCTGCTGGGCGTGGGCGCGATGGGTCTGGAC
GCGGTACCAATTGAAGGTTTCGACGCCGCTATTCTCGACGAAGAGTTTGGCCTGAAAGAG
AAAGGCTTCACCAGCCTGGTGGTGGTACCGGTTGGGCACCACAGCGTGGAAGATTTCAAC
GCCACGCTGCCGAAATCTCGCCTGCCGCTGAGCACGATTGTGACCGAGTGCTGA

# Drug_Target_10_General_Function:
Involved in oxidoreductase activity

# Drug_Target_10_General_References:
1999405	Bryant C, DeLuca M: Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae. J Biol Chem. 1991 Mar 5;266(7):4119-25.
1999406	Bryant C, Hubbard L, McElroy WD: Cloning, nucleotide sequence, and expression of the nitroreductase gene from Enterobacter cloacae. J Biol Chem. 1991 Mar 5;266(7):4126-30.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
5184

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
23950

# Drug_Target_10_Name:
Oxygen-insensitive NAD(P)H nitroreductase

# Drug_Target_10_Number_of_Residues:
217

# Drug_Target_10_PDB_ID:
1KQD

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00881	Nitroreductase

# Drug_Target_10_Protein_Sequence:
>Oxygen-insensitive NAD(P)H nitroreductase
MDIISVALKRHSTKAFDASKKLTAEEAEKIKTLLQYSPSSTNSQPWHFIVASTEEGKARV
AKSAAGTYVFNERKMLDASHVVVFCAKTAMDDAWLERVVDQEEADGRFNTPEAKAANHKG
RTYFADMHRVDLKDDDQWMAKQVYLNVGNFLLGVGAMGLDAVPIEGFDAAILDEEFGLKE
KGFTSLVVVPVGHHSVEDFNATLPKSRLPLSTIVTEC

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Reduction of a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred

# Drug_Target_10_SwissProt_ID:
Q01234

# Drug_Target_10_SwissProt_Name:
NFNB_ENTCL

# Drug_Target_10_Synonyms:
EC 1.-.-.-
NR

# Drug_Target_10_Theoretical_pI:
5.61

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
AY822041

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
chqB

# Drug_Target_11_Gene_Sequence:
>882 bp
ATGAGCACGCCCGTCTCCGCCGAGCAGCAGGCCCGCGAGCAGGACCTGGTCGAGCGCGTG
CTGCGCTCCTTCGACGCCACCGCCGACCCGCGCCTGAAGCAGGTGATGCAGGCGCTGACC
CGGCACCTGCACGCCTTCCTGCGCGAGGTGCGGCTGACCGAGGCGGAGTGGGAGACCGGG
ATCGGCTTCCTGACCGACGCCGGTCACGTCACCAACGAGCGACGCCAGGAGTTCATCCTG
CTCTCCGACGTCCTCGGCGCGTCGATGCAGACGATCGCGATGAACAACGAGGCCCACGGC
GACGCCACCGAGGCCACCGTCTTCGGACCGTTCTTCGTCGAGGGGTCGCCGCGGATCGAG
TCCGGCGGTGACATCGCCGGTGGCGCGGCCGGCGAGCCGTGCTGGGTCGAGGGCACGGTC
ACCGACACCGACGGCAACCCCGTGCCCGATGCGCGGATCGAGGTGTGGGAGGCCGACGAC
GACGGCTTCTACGACGTCCAGTACGACGACGACCGCACCGCCGCGCGCGCCCACCTGCTC
AGCGGCCCGGACGGAGGCTATGCGTTCTGGGCGATCACGCCGACCCCCTACCCGATCCCC
CACGACGGGCCGGTCGGCCGGATGCTCGCCGCCACCGGCCGCTCCCCCATGCGCGCCTCG
CACCTGCACTTCATGGTCACCGCGCCCGGGCGGCGCACGTTGGTCACGCACATCTTCGTC
GAGGGCGACGAGCTGCTCGACCGCGACTCGGTGTTCGGCGTGAAGGACTCGCTTGTCAAG
AGCTTCGAGCGGCAGCCGGCCGGCGCGCCCACTCCCGGCGGCCGCGAGATCGACGGCCCC
TGGTCGCGGGTGCGCTTCGACATCGTCCTCGCTCCCGCCTGA

# Drug_Target_11_General_Function:
Involved in iron ion binding

# Drug_Target_11_General_References:
9141483	Travkin VM, Jadan AP, Briganti F, Scozzafava A, Golovleva LA: Characterization of an intradiol dioxygenase involved in the biodegradation of the chlorophenoxy herbicides 2,4-D and 2,4,5-T. FEBS Lett. 1997 Apr 21;407(1):69-72.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
5427

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
31967

# Drug_Target_11_Name:
Hydroxyquinol 1,2-dioxygenase

# Drug_Target_11_Number_of_Residues:
293

# Drug_Target_11_PDB_ID:
1TMX

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00775	Dioxygenase_C
PF04444	Dioxygenase_N

# Drug_Target_11_Protein_Sequence:
>Hydroxyquinol 1,2-dioxygenase
MSTPVSAEQQAREQDLVERVLRSFDATADPRLKQVMQALTRHLHAFLREVRLTEAEWETG
IGFLTDAGHVTNERRQEFILLSDVLGASMQTIAMNNEAHGDATEATVFGPFFVEGSPRIE
SGGDIAGGAAGEPCWVEGTVTDTDGNPVPDARIEVWEADDDGFYDVQYDDDRTAARAHLL
SGPDGGYAFWAITPTPYPIPHDGPVGRMLAATGRSPMRASHLHFMVTAPGRRTLVTHIFV
EGDELLDRDSVFGVKDSLVKSFERQPAGAPTPGGREIDGPWSRVRFDIVLAPA

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Catalyzes the ortho-cleavage of the aromatic ring of hydroxyquinol

# Drug_Target_11_SwissProt_ID:
Q5PXQ6

# Drug_Target_11_SwissProt_Name:
CHQB_NOCSI

# Drug_Target_11_Synonyms:
1,2-HQD
EC 1.13.11.37

# Drug_Target_11_Theoretical_pI:
4.50

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
X58896

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
repA

# Drug_Target_12_Gene_Sequence:
>696 bp
GTGATGGTCGAGAACAAAGTCACGCAGTCCAATAAACTCATCGAATCGTCACATACGTTG
ACACTCAATGAGAAACGCCTAGTGCTATGCGCTGCGTCTTTGATCGATTCACGTAAGCCA
CTCCCTAAAGATGGTTACTTGACCATCCGAGCTGACACCTTCGCTGAGGTGTTTGGAATT
GATGTCAAACACGCCTATGCGGCATTAGATGACGCTGCCACAAAGTTGTTTAACCGAGAT
ATTCGCAGGTACGTCAAAGGCAAAGTCGTTGAACGCATGCGCTGGGTTTTTCACGTCAAG
TACAGGGAAGGCCAAGGCTGCGTCGAGCTAGGATTTTCTCCTACGATAATCCCGCATCTA
ACCATGCTGCACAAAGAGTTCACCAGCTATCAGCTCAAGCAAATCGGTAGCCTGTCCAGC
TTCTACGCTGTCCGCCTTTACGAGCTTATGAGCCAATTTATCAAGCTCAAACAGCGGGAA
TGCACACTCGCCCAACTGCGGGAAATGTTCGACCTTGGTGACAAGTACCAAGACGTTAAG
GACATGCGTAAGCGTGTGCTATATCCCGCTTTAGAGGAAGTGAACAAGAACACCGATTTG
ACAGTGGCAGTGGAGCCTCGCCGACAGGGCCGACGAATCATTGGGTTCTCATTCACGATC
GCTAAAAACGATCAACTGGCACTGAGTCTCGAGTGA

# Drug_Target_12_General_Function:
Involved in DNA-directed DNA polymerase activity

# Drug_Target_12_General_References:
1738155	Nieto C, Giraldo R, Fernandez-Tresguerres E, Diaz R: Genetic and functional analysis of the basic replicon of pPS10, a plasmid specific for Pseudomonas isolated from Pseudomonas syringae patovar savastanoi. J Mol Biol. 1992 Jan 20;223(2):415-26.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
5428

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
26729

# Drug_Target_12_Name:
Replication protein

# Drug_Target_12_Number_of_Residues:
231

# Drug_Target_12_PDB_ID:
1HKQ

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF01051	Rep_3

# Drug_Target_12_Protein_Sequence:
>Replication protein
MMVENKVTQSNKLIESSHTLTLNEKRLVLCAASLIDSRKPLPKDGYLTIRADTFAEVFGI
DVKHAYAALDDAATKLFNRDIRRYVKGKVVERMRWVFHVKYREGQGCVELGFSPTIIPHL
TMLHKEFTSYQLKQIGSLSSFYAVRLYELMSQFIKLKQRECTLAQLREMFDLGDKYQDVK
DMRKRVLYPALEEVNKNTDLTVAVEPRRQGRRIIGFSFTIAKNDQLALSLE

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Not Available

# Drug_Target_12_SwissProt_ID:
Q52546

# Drug_Target_12_SwissProt_Name:
Q52546_PSESX

# Drug_Target_12_Synonyms:
Not Available

# Drug_Target_12_Theoretical_pI:
9.85

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Mitochondrion. Cytoplasm. Peroxisome

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
PRDX5

# Drug_Target_13_GenBank_ID_Gene:
AJ249483

# Drug_Target_13_GenBank_ID_Protein:
6523289

# Drug_Target_13_GeneCard_ID:
PRDX5

# Drug_Target_13_Gene_Name:
PRDX5

# Drug_Target_13_Gene_Sequence:
>645 bp
ATGGGACTAGCTGGCGTGTGCGCCCTGAGACGCTCAGCGGGCTATATACTCGTCGGTGGG
GCCGGCGGTCAGTCTGCGGCAGCGGCAGCAAGACGGTGCAGTGAAGGAGAGTGGGCGTCT
GGCGGGGTCCGCAGTTTCAGCAGAGCCGCTGCAGCCATGGCCCCAATCAAGGTGGGAGAT
GCCATCCCAGCAGTGGAGGTGTTTGAAGGGGAGCCAGGGAACAAGGTGAACCTGGCAGAG
CTGTTCAAGGGCAAGAAGGGTGTGCTGTTTGGAGTTCCTGGGGCCTTCACCCCTGGATGT
TCCAAGACACACCTGCCAGGGTTTGTGGAGCAGGCTGAGGCTCTGAAGGCCAAGGGAGTC
CAGGTGGTGGCCTGTCTGAGTGTTAATGATGCCTTTGTGACTGGCGAGTGGGGCCGAGCC
ACAAAGGCGGAAGGCAAGGTTCGGCTCCTGGCTGATCCCACTGGGGCCTTTGGGAAGGAG
ACAGACTTATTACTAGATGATTCGCTGGTGTCCATCTTTGGGAATCGACGTCTCAAGAGG
TTCTCCATGGTGGTACAGGATGGCATAGTGAAGGCCCTGAATGTGGAACCAGATGGCACA
GGCCTCACCTGCAGCCTGGCACCCAATATCATCTCACAGCTCTGA

# Drug_Target_13_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_13_General_References:
10095767	Kropotov A, Sedova V, Ivanov V, Sazeeva N, Tomilin A, Krutilina R, Oei SL, Griesenbeck J, Buchlow G, Tomilin N: A novel human DNA-binding protein with sequence similarity to a subfamily of redox proteins which is able to repress RNA-polymerase-III-driven transcription of the Alu-family retroposons in vitro. Eur J Biochem. 1999 Mar;260(2):336-46.
10514471	Yamashita H, Avraham S, Jiang S, London R, Van Veldhoven PP, Subramani S, Rogers RA, Avraham H: Characterization of human and murine PMP20 peroxisomal proteins that exhibit antioxidant activity in vitro. J Biol Chem. 1999 Oct 15;274(42):29897-904.
10521424	Knoops B, Clippe A, Bogard C, Arsalane K, Wattiez R, Hermans C, Duconseille E, Falmagne P, Bernard A: Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J Biol Chem. 1999 Oct 22;274(43):30451-8.
10679306	Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW, Lin MC, Fung PC, Kung H, Jin DY: Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun. 2000 Feb 24;268(3):921-7.
10751410	Seo MS, Kang SW, Kim K, Baines IC, Lee TH, Rhee SG: Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem. 2000 Jul 7;275(27):20346-54.
10931946	Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, Gu YJ, Huang CH, Li YB, Jiang CL, Fu G, Zhang QH, Gu BW, Dai M, Mao YF, Gao GF, Rong R, Ye M, Zhou J, Xu SH, Gu J, Shi JX, Jin WR, Zhang CK, Wu TM, Huang GY, Chen Z, Chen MD, Chen JL: Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9543-8.
11518528	Declercq JP, Evrard C, Clippe A, Stricht DV, Bernard A, Knoops B: Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 A resolution. J Mol Biol. 2001 Aug 24;311(4):751-9.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.

# Drug_Target_13_HGNC_ID:
HGNC:9355

# Drug_Target_13_HPRD_ID:
05958

# Drug_Target_13_ID:
1119

# Drug_Target_13_Locus:
11q13

# Drug_Target_13_Molecular_Weight:
22027

# Drug_Target_13_Name:
Peroxiredoxin-5, mitochondrial

# Drug_Target_13_Number_of_Residues:
214

# Drug_Target_13_PDB_ID:
1OC3

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF08534	Redoxin

# Drug_Target_13_Protein_Sequence:
>Peroxiredoxin-5, mitochondrial precursor
MGLAGVCALRRSAGYILVGGAGGQSAAAAARRCSEGEWASGGVRSFSRAAAAMAPIKVGD
AIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGV
QVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKR
FSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL

# Drug_Target_13_Reaction:
2 R'-SH + ROOH = R'-S-S-R' + H2O + ROH

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Reduces hydrogen peroxide and alkyl hydroperoxides with reducing equivalents provided through the thioredoxin system. Involved in intracellular redox signaling

# Drug_Target_13_SwissProt_ID:
P30044

# Drug_Target_13_SwissProt_Name:
PRDX5_HUMAN

# Drug_Target_13_Synonyms:
AOEB166
Alu corepressor 1
Antioxidant enzyme B166
EC 1.11.1.15
Liver tissue 2D-page spot 71B
PLP
Peroxiredoxin-5, mitochondrial precursor
Peroxisomal antioxidant enzyme
Prx-V
TPx type VI
Thioredoxin peroxidase PMP20
Thioredoxin reductase

# Drug_Target_13_Theoretical_pI:
8.77

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Not Available

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
M17873

# Drug_Target_14_GenBank_ID_Protein:
145833

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
eltB

# Drug_Target_14_Gene_Sequence:
>375 bp
ATGAATAAAGTAAAATGTTATGTTTTATTTACGGCGTTACTATCCTCTCTATATGCACAC
GGAGCTCCCCAGACTATTACAGAACTATGTTCGGAATATCGCAACACACAAATATATACG
ATAAATGACAAGATACTATCATATACGGAATCGATGGCAGGCAAAAGAGAAATGGTTATC
ATTACATTTAAGAGCGGCGAAACATTTCAGGTCGAAGTCCCGGGCAGTCAACATATAGAC
TCCCAGAAAAAAGCCATTGAAAGGATGAAGGACACATTAAGAATCACATATCTGACCGAG
ACCAAAATTGATAAATTATGTGTATGGAATAATAAAACCCCCAATTCAATTGCGGCAATC
AGTATGAAAAACTAG

# Drug_Target_14_General_Function:
Not Available

# Drug_Target_14_General_References:
11880036	Pickens JC, Merritt EA, Ahn M, Verlinde CL, Hol WG, Fan E: Anchor-based design of improved cholera toxin and E. coli heat-labile enterotoxin receptor binding antagonists that display multiple binding modes. Chem Biol. 2002 Feb;9(2):215-24.
2034287	Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BA, Witholt B, Hol WG: Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature. 1991 May 30;351(6325):371-7.
3301830	Ibrahimi I, Gentz R: A functional interaction between the signal peptide and the translation apparatus is detected by the use of a single point mutation which blocks translocation across mammalian endoplasmic reticulum. J Biol Chem. 1987 Jul 25;262(21):10189-94.
3333803	Tsuji T, Iida T, Honda T, Miwatani T, Nagahama M, Sakurai J, Wada K, Matsubara H: A unique amino acid sequence of the B subunit of a heat-labile enterotoxin isolated from a human enterotoxigenic Escherichia coli. Microb Pathog. 1987 May;2(5):381-90.
3546273	Yamamoto T, Gojobori T, Yokota T: Evolutionary origin of pathogenic determinants in enterotoxigenic Escherichia coli and Vibrio cholerae O1. J Bacteriol. 1987 Mar;169(3):1352-7.
3884513	Leong J, Vinal AC, Dallas WS: Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin. Infect Immun. 1985 Apr;48(1):73-7.
7003397	Dallas WS, Falkow S: Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature. 1980 Dec 4;288(5790):499-501.
7623669	Domenighini M, Pizza M, Jobling MG, Holmes RK, Rappuoli R: Identification of errors among database sequence entries and comparison of correct amino acid sequences for the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae. Mol Microbiol. 1995 Mar;15(6):1165-7.
8478941	Sixma TK, Kalk KH, van Zanten BA, Dauter Z, Kingma J, Witholt B, Hol WG: Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J Mol Biol. 1993 Apr 5;230(3):890-918.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
2693

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
14134

# Drug_Target_14_Name:
Heat-labile enterotoxin B chain

# Drug_Target_14_Number_of_Residues:
124

# Drug_Target_14_PDB_ID:
1PZI

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF01376	Enterotoxin_b

# Drug_Target_14_Protein_Sequence:
>Heat-labile enterotoxin B chain precursor
MNKVKCYVLFTALLSSLYAHGAPQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVI
ITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAI
SMKN

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
1-21

# Drug_Target_14_Specific_Function:
The biological activity of the toxin is produced by the A chain, which activates intracellular adenyl cyclase

# Drug_Target_14_SwissProt_ID:
P32890

# Drug_Target_14_SwissProt_Name:
ELBP_ECOLX

# Drug_Target_14_Synonyms:
Heat-labile enterotoxin B chain precursor
LT-B, porcine
LTP-B

# Drug_Target_14_Theoretical_pI:
9.12

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
AF173165

# Drug_Target_15_GenBank_ID_Protein:
7229394

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
cocE

# Drug_Target_15_Gene_Sequence:
>1725 bp
ATGGTGGACGGGAATTACAGTGTTGCCTCGAACGTGATGGTTCCGATGCGTGATGGGGTG
CGTCTGGCGGTCGACCTGTACCGACCAGATGCTGATGGACCTGTTCCGGTCCTGCTGGTT
CGCAACCCATACGACAAGTTCGACGTGTTCGCGTGGTCGACGCAGTCGACAAACTGGCTT
GAGTTCGTGCGTGATGGCTATGCCGTGGTCATTCAAGACACGCGTGGCTTGTTCGCATCG
GAAGGTGAGTTCGTCCCGCACGTTGACGACGAAGCTGACGCCGAGGATACGTTGAGCTGG
ATTCTGGAACAAGCGTGGTGCGACGGCAATGTGGGCATGTTCGGCGTTTCGTACTTGGGT
GTGACCCAGTGGCAGGCCGCCGTATCCGGCGTTGGTGGGCTGAAGGCGATCGCGCCGTCC
ATGGCGTCGGCGGACTTGTACCGCGCCCCGTGGTACGGCCCTGGTGGTGCGCTTTCAGTC
GAGGCGCTGTTGGGCTGGTCAGCTCTCATAGGTACTGGGCTCATCACGTCGAGGTCTGAC
GCCCGGCCCGAAGACGCAGCCGACTTCGTCCAACTCGCAGCAATTCTCAATGACGTCGCT
GGCGCGGCGTCGGTCACGCCCCTGGCCGAGCAACCGCTTCTGGGCCGACTGATTCCGTGG
GTGATCGATCAGGTTGTCGATCACCCCGACAACGATGAATCATGGCAGTCCATTAGCTTG
TTTGAACGACTCGGCGGGTTGGCAACACCGGCCTTGATCACGGCTGGGTGGTACGACGGG
TTCGTCGGCGAATCGTTGCGCACTTTCGTTGCGGTCAAGGACAATGCCGACGCACGTTTG
GTTGTCGGCCCTTGGAGTCACAGCAACCTCACTGGTCGGAATGCGGACCGGAAGTTCGGC
ATTGCCGCGACCTACCCGATTCAAGAAGCCACCACGATGCACAAGGCATTCTTCGACCGG
CACCTCCGCGGCGAGACCGATGCACTCGCAGGCGTCCCCAAAGTGCGGCTGTTCGTAATG
GGCATCGATGAGTGGCGTGACGAAACGGACTGGCCACTGCCGGACACGGCGTATACGCCC
TTCTATCTTGGAGGTAGCGGGGCTGCGAATACCTCCACGGGTGGTGGAACACTGTCGACG
TCGATTTCCGGAACTGAATCTGCTGACACCTACCTGTATGATCCGGCCGATCCCGTGCCT
TCGCTCGGGGGGACGCTGCTGTTCCACAACGGAGACAACGGACCCGCCGACCAACGTCCC
ATTCATGACCGGGACGACGTGTTGTGTTACAGCACTGAGGTATTGACCGACCCGGTGGAA
GTAACCGGCACCGTCTCCGCCCGGCTGTTCGTGTCGTCATCAGCGGTGGACACTGATTTC
ACCGCCAAACTTGTCGACGTATTTCCCGACGGTCGCGCGATCGCGCTGTGTGACGGGATC
GTGCGGATGCGGTACCGCGAGACGTTGGTCAATCCAACCTTGATCGAAGCGGGCGAAATC
TACGAGGTTGCTATCGACATGCTTGCAACCTCGAATGTATTCCTGCCAGGGCATCGCATC
ATGGTCCAAGTATCAAGTAGCAACTTCCCGAAATACGACCGCAATTCGAATACCGGCGGA
GTAATCGCACGGGAACAGCTCGAAGAGATGTGCACCGCCGTGAACCGCATTCACCGAGGA
CCTGAGCATCCCAGCCACATTGTGCTGCCGATTATCAAGCGATAG

# Drug_Target_15_General_Function:
Involved in hydrolase activity

# Drug_Target_15_General_References:
10698749	Bresler MM, Rosser SJ, Basran A, Bruce NC: Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl Environ Microbiol. 2000 Mar;66(3):904-8.
11742345	Larsen NA, Turner JM, Stevens J, Rosser SJ, Basran A, Lerner RA, Bruce NC, Wilson IA: Crystal structure of a bacterial cocaine esterase. Nat Struct Biol. 2002 Jan;9(1):17-21.
12369817	Turner JM, Larsen NA, Basran A, Barbas CF 3rd, Bruce NC, Wilson IA, Lerner RA: Biochemical characterization and structural analysis of a highly proficient cocaine esterase. Biochemistry. 2002 Oct 15;41(41):12297-307.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
2573

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
62132

# Drug_Target_15_Name:
Cocaine esterase

# Drug_Target_15_Number_of_Residues:
574

# Drug_Target_15_PDB_ID:
1JU4

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF02129	Peptidase_S15
PF08530	PepX_C

# Drug_Target_15_Protein_Sequence:
>Cocaine esterase
MVDGNYSVASNVMVPMRDGVRLAVDLYRPDADGPVPVLLVRNPYDKFDVFAWSTQSTNWL
EFVRDGYAVVIQDTRGLFASEGEFVPHVDDEADAEDTLSWILEQAWCDGNVGMFGVSYLG
VTQWQAAVSGVGGLKAIAPSMASADLYRAPWYGPGGALSVEALLGWSALIGTGLITSRSD
ARPEDAADFVQLAAILNDVAGAASVTPLAEQPLLGRLIPWVIDQVVDHPDNDESWQSISL
FERLGGLATPALITAGWYDGFVGESLRTFVAVKDNADARLVVGPWSHSNLTGRNADRKFG
IAATYPIQEATTMHKAFFDRHLRGETDALAGVPKVRLFVMGIDEWRDETDWPLPDTAYTP
FYLGGSGAANTSTGGGTLSTSISGTESADTYLYDPADPVPSLGGTLLFHNGDNGPADQRP
IHDRDDVLCYSTEVLTDPVEVTGTVSARLFVSSSAVDTDFTAKLVDVFPDGRAIALCDGI
VRMRYRETLVNPTLIEAGEIYEVAIDMLATSNVFLPGHRIMVQVSSSNFPKYDRNSNTGG
VIAREQLEEMCTAVNRIHRGPEHPSHIVLPIIKR

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Hydrolyzes cocaine to benzoate and ecgonine methyl ester, endowing the bacteria with the ability to utilize cocaine as a sole source of carbon and energy for growth, as this bacterium lives in the rhizosphere of coca plants

# Drug_Target_15_SwissProt_ID:
Q9L9D7

# Drug_Target_15_SwissProt_Name:
COCE_RHOSM

# Drug_Target_15_Synonyms:
EC 3.1.1.-

# Drug_Target_15_Theoretical_pI:
4.31

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
J04553

# Drug_Target_1_GenBank_ID_Protein:
147042

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
oxyR

# Drug_Target_1_Gene_Sequence:
>918 bp
ATGAATATTCGTGATCTTGAGTACCTGGTGGCATTGGCTGAACACCGCCATTTTCGGCGT
GCGGCAGATTCCTGCCACGTTAGCCAGCCGACGCTTAGCGGGCAAATTCGTAAGCTGGAA
GATGAGCTGGGCGTGATGTTGCTGGAGCGGACCAGCCGTAAAGTGTTGTTCACCCAGGCG
GGAATGCTGCTGGTGGATCAGGCGCGTACCGTGCTGCGTGAGGTGAAAGTCCTTAAAGAG
ATGGCAAGCCAGCAGGGCGAGACGATGTCCGGACCGCTGCACATTGGTTTGATTCCCACA
GTTGGACCGTACCTGCTACCGCATATTATCCCTATGCTGCACCAGACCTTTCCAAAGCTG
GAAATGTATCTGCATGAAGCACAGACCCACCAGTTACTGGCGCAACTGGACAGCGGCAAA
CTCGATTGCGTGATCCTCGCGCTGGTGAAAGAGAGCGAACGATTCATTGAAGTGCCGTTG
TTTGATGAGCCAATGTTGCTGGCTATCTATGAAGATCACCCGTGGGCGAACCGCGAATGC
GTACCGATGGCCGATCTGGCAGGGGAAAAACTGCTGATGCTGGAAGATGGTCACTGTTTG
CGCGATCAGGCAATGGGTTTCTGTTTTGAAGCCGGGGCGGATGAAGATACACACTTCCGC
GCGACCAGCCTGGAAACTCTGCGCAACATGGTGGCGGCAGGTAGCGGGATCACTTTACTG
CCAGCGCTGGCTGTGCCGCCGGAGCGCAAACGCGATGGGGTTGTTTATCTGCCGTGCATT
AAGCCGGAACCACGCCGCACTATTGGCCTGGTTTATCGTCCTGGCTCACCGCTGCGCAGC
CGCTATGAGCAGCTGGCAGAGGCCATCCGCGCAAGAATGGATGGCCATTTCGATAAAGTT
TTAAAACAGGCGGTTTAA

# Drug_Target_1_General_Function:
Transcription

# Drug_Target_1_General_References:
12015987	Kim SO, Merchant K, Nudelman R, Beyer WF Jr, Keng T, DeAngelo J, Hausladen A, Stamler JS: OxyR: a molecular code for redox-related signaling. Cell. 2002 May 3;109(3):383-96.
1864839	Tao K, Makino K, Yonei S, Nakata A, Shinagawa H: Purification and characterization of the Escherichia coli OxyR protein, the positive regulator for a hydrogen peroxide-inducible regulon. J Biochem (Tokyo). 1991 Feb;109(2):262-6.
2167922	Warne SR, Varley JM, Boulnois GJ, Norton MG: Identification and characterization of a gene that controls colony morphology and auto-aggregation in Escherichia coli K12. J Gen Microbiol. 1990 Mar;136(3):455-62.
2471187	Christman MF, Storz G, Ames BN: OxyR, a positive regulator of hydrogen peroxide-inducible genes in Escherichia coli and Salmonella typhimurium, is homologous to a family of bacterial regulatory proteins. Proc Natl Acad Sci U S A. 1989 May;86(10):3484-8.
2511419	Tao K, Makino K, Yonei S, Nakata A, Shinagawa H: Molecular cloning and nucleotide sequencing of oxyR, the positive regulatory gene of a regulon for an adaptive response to oxidative stress in Escherichia coli: homologies between OxyR protein and a family of bacterial activator proteins. Mol Gen Genet. 1989 Sep;218(3):371-6.
2551682	Bolker M, Kahmann R: The Escherichia coli regulatory protein OxyR discriminates between methylated and unmethylated states of the phage Mu mom promoter. EMBO J. 1989 Aug;8(8):2403-10.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9497290	Zheng M, Aslund F, Storz G: Activation of the OxyR transcription factor by reversible disulfide bond formation. Science. 1998 Mar 13;279(5357):1718-21.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3718

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34277

# Drug_Target_1_Name:
Hydrogen peroxide-inducible genes activator

# Drug_Target_1_Number_of_Residues:
305

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00126	HTH_1
PF03466	LysR_substrate

# Drug_Target_1_Protein_Sequence:
>Hydrogen peroxide-inducible genes activator
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQA
GMLLVDQARTVLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKL
EMYLHEAQTHQLLAQLDSGKLDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANREC
VPMADLAGEKLLMLEDGHCLRDQAMGFCFEAGADEDTHFRATSLETLRNMVAAGSGITLL
PALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRSRYEQLAEAIRARMDGHFDKV
LKQAV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Hydrogen peroxide sensor. Activates the expression of a regulon of hydrogen peroxide-inducible genes such as katG, gor, ahpC, ahpF, oxyS (a regulatory RNA), dps, fur and grxA. OxyR expression is negatively autoregulated by binding to a 43 bp region upstream of its own coding sequence. OxyR is inactivated by reduction of its essential disulfide bond by the product of grxA, itself positively regulated by OxyR. Has also a positive regulatory effect on the production of surface proteins that control the colony morphology and auto-aggregation ability

# Drug_Target_1_SwissProt_ID:
P0ACQ4

# Drug_Target_1_SwissProt_Name:
OXYR_ECOLI

# Drug_Target_1_Synonyms:
Morphology and auto- aggregation control protein

# Drug_Target_1_Theoretical_pI:
6.37

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M13585

# Drug_Target_2_GenBank_ID_Protein:
146717

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
malT

# Drug_Target_2_Gene_Sequence:
>2706 bp
ATGCTGATTCCGTCAAAACTAAGTCGTCCGGTTCGACTCGACCATACCGTGGTTCGTGAG
CGCCTGCTGGCTAAACTTTCCGGCGCGAACAACTTCCGGCTGGCGCTGATCACGAGTCCT
GCGGGCTACGGAAAGACCACCCTCATTTCCCAGTGGGCGGCAGGCAAAAACGATATCGGC
TGGTACTCGCTGGATGAAGGTGATAACCAGCAAGAGCGTTTCGCCAGCTATCTCATTGCC
GCCGTGCAGCAGGCAACCAACGGTCACTGTGCGATATGTGAGACGATGGCGCAAAAACGG
CAATATGCCAGCCTGACGTCACTCTTCGCCCAGCTTTTCATTGAGCTGGCGGAATGGCAT
AGCCCACTTTATCTGGTCATCGATGACTATCATCTGATCACTAATCCAGTGATCCACGAG
TCAATGCGCTTCTTTATTCGCCATCAACCAGAAAATCTCACCCTGGTGGTGTTGTCACGC
AACCTTCCGCAACTGGGCATTGCCAATCTGCGTGTTCGTGATCAACTGCTGGAAATTGGC
AGTCAGCAACTGGCATTTACCCATCAGGAAGCGAACGAGTTTTTTGATTGCCGTCTGTCA
TCGCCGATTGAAGCCGCAGAAAGCAGTCGGATTTGCGATGACGTTTCCGGTTGGGCGACG
GCACTACAGCTAATCGCCCTCTCCGCCCGGCAGAATACCCACTCAGCCCATAAGTCGGCA
CGCCGCCTGGCGGGAATCAATGCCAGCCATCTTTCGGATTATCTGGTCGATGAGGTTTTG
GATAACGTCGATCTCGCAACGCGCCATTTTCTGTTGAAAAGCGCCATTTTGCGCTCAATG
AACGATGCCCTCATCACCCGTGTGACCGGCGAAGAAAACGGGCAAATGCGCCTCGAAGAG
ATTGAGCGTCAGGGGCTGTTTTTACAGCGGATGGATGATACCGGCGAGTGGTTCTGCTAT
CACCCGCTGTTTGGTAACTTCCTGCGCCAGCGCTGCCAGTGGGAACTGGCGGCGGAGCTG
CCGGAAATCCACCGTGCCGCCGCAGAAAGCTGGATGGCCCAGGGATTTCCCAGCGAAGCA
ATTCATCATGCGCTGGCGGCAGGCGATGCGCTGATGCTGCGCGATATTCTGCTTAATCAC
GCCTGGAGTCTGTTCAACCATAGCGAACTGTCGCTGCTGGAAGAGTCGCTTAAGGCCCTG
CCGTGGGACAGCTTGCTGGAAAATCCGCAGTTGGTGTTATTGCAGGCGTGGCTGATGCAA
AGCCAACATCGCTACGGCGAAGTTAACACCCTGCTAGCCCGTGCTGAACATGAAATCAAG
GACATCAGAGAAGACACCATGCACGCAGAATTTAACGCTCTGCGCGCCCAGGTGGCGATT
AACGATGGTAATCCGGATGAAGCGGAACGGCTGGCAAAACTGGCACTGGAAGAGCTGCCG
CCGGGCTGGTTCTATAGCCGCATTGTGGCAACCTCGGTGCTGGGTGAAGTGCTGCACTGC
AAAGGCGAATTGACCCGCTCACTGGCGCTAATGCAGCAAACCGAACAGATGGCACGCCAG
CACGATGTCTGGCACTACGCTTTGTGGAGTTTAATCCAGCAAAGTGAAATTCTGTTTGCC
CAAGGGTTCCTGCAAACCGCGTGGGAAACGCAGGAAAAAGCATTCCAGCTGATCAACGAG
CAGCATCTGGAACAGCTGCCAATGCATGAGTTTCTGGTGCGCATTCGTGCGCAGCTGTTA
TGGGCCTGGGCGCGGCTGGATGAAGCCGAAGCGTCGGCGCGTAGCGGGATTGAAGTCTTG
TCGTCTTATCAGCCACAGCAACAGCTTCAGTGCCTGGCAATGTTGATTCAATGCTCGCTG
GCCCGTGGTGATTTAGATAACGCCCGTAGCCAGCTGAACCGTCTGGAAAACCTGCTGGGG
AATGGCAAATATCACAGCGACTGGATCTCTAACGCCAACAAAGTCCGGGTGATTTACTGG
CAAATGACCGGCGATAAAGCCGCCGCTGCCAACTGGTTGCGTCATACGGCTAAACCAGAG
TTTGCGAACAACCACTTCCTGCAAGGTCAATGGCGCAACATTGCCCGTGCACAAATCTTG
CTGGGCGAGTTTGAACCGGCAGAAATTGTTCTCGAAGAACTCAATGAAAATGCCCGGAGT
CTGCGGTTGATGAGCGATCTCAACCGTAACCTGTTGCTGCTTAATCAACTGTACTGGCAG
GCCGGACGTAAAAGTGACGCCCAGCGCGTGTTGCTGGACGCATTAAAACTGGCGAATCGC
ACCGGATTTATCAGCCATTTTGTCATCGAAGGCGAAGCGATGGCGCAACAACTGCGTCAG
CTGATTCAGCTTAATACGCTGCCGGAACTGGAACAGCATCGCGCGCAGCGTATTCTGCGA
GAAATCAATCAACATCATCGGCATAAATTCGCCCATTTCGATGAGAATTTCGTTGAACGT
CTGCTAAATCATCCTGAAGTACCTGAACTGATCCGCACCAGCCCGCTGACGCAACGTGAA
TGGCAGGTACTGGGGCTGATCTACTCTGGTTACAGCAATGAGCAAATTGCCGGAGAACTG
GAAGTCGCGGCAACCACCATCAAAACGCATATCCGCAATCTGTATCAGAAACTCGGCGTG
GCCCATCGCCAGGATGCGGTACAACACGCCCAGCAATTGCTGAAGATGATGGGGTACGGC
GTGTAA

# Drug_Target_2_General_Function:
Transcription

# Drug_Target_2_General_References:
11709169	Steegborn C, Danot O, Huber R, Clausen T: Crystal structure of transcription factor MalT domain III: a novel helix repeat fold implicated in regulated oligomerization. Structure. 2001 Nov;9(11):1051-60.
12003949	Schlegel A, Danot O, Richet E, Ferenci T, Boos W: The N terminus of the Escherichia coli transcription activator MalT is the domain of interaction with MalY. J Bacteriol. 2002 Jun;184(11):3069-77.
2524384	Richet E, Raibaud O: MalT, the regulatory protein of the Escherichia coli maltose system, is an ATP-dependent transcriptional activator. EMBO J. 1989 Mar;8(3):981-7.
3015733	Cole ST, Raibaud O: The nucleotide sequence of the malT gene encoding the positive regulator of the Escherichia coli maltose regulon. Gene. 1986;42(2):201-8.
6283313	Debarbouille M, Cossart P, Raibaud O: A DNA sequence containing the control sites for gene malT and for the malPQ operon. Mol Gen Genet. 1982;185(1):88-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3018

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
103120

# Drug_Target_2_Name:
HTH-type transcriptional regulator malT

# Drug_Target_2_Number_of_Residues:
901

# Drug_Target_2_PDB_ID:
1HZ4

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00196	GerE

# Drug_Target_2_Protein_Sequence:
>HTH-type transcriptional regulator malT
MLIPSKLSRPVRLDHTVVRERLLAKLSGANNFRLALITSPAGYGKTTLISQWAAGKNDIG
WYSLDEGDNQQERFASYLIAAVQQATNGHCAICETMAQKRQYASLTSLFAQLFIELAEWH
SPLYLVIDDYHLITNPVIHESMRFFIRHQPENLTLVVLSRNLPQLGIANLRVRDQLLEIG
SQQLAFTHQEAKQFFDCRLSSPIEAAESSRICDDVSGWATALQLIALSARQNTHSAHKSA
RRLAGINASHLSDYLVDEVLDNVDLATRHFLLKSAILRSMNDALITRVTGEENGQMRLEE
IERQGLFLQRMDDTGEWFCYHPLFGNFLRQRCQWELAAELPEIHRAAAESWMAQGFPSEA
IHHALAAGDALMLRDILLNHAWSLFNHSELSLLEESLKALPWDSLLENPQLVLLQAWLMQ
SQHRYGEVNTLLARAEHEIKDIREDTMHAEFNALRAQVAINDGNPDEAERLAKLALEELP
PGWFYSRIVATSVLGEVLHCKGELTRSLALMQQTEQMARQHDVWHYALWSLIQQSEILFA
QGFLQTAWETQEKAFQLINEQHLEQLPMHEFLVRIRAQLLWAWARLDEAEASARSGIEVL
SSYQPQQQLQCLAMLIQCSLARGDLDNARSQLNRLENLLGNGKYHSDWISNANKVRVIYW
QMTGDKAAAANWLRHTAKPEFANNHFLQGQWRNIARAQILLGEFEPAEIVLEELNENARS
LRLMSDLNRNLLLLNQLYWQAGRKSDAQRVLLDALKLANRTGFISHFVIEGEAMAQQLRQ
LIQLNTLPELEQHRAQRILREINQHHRHKFAHFDENFVERLLNHPEVPELIRTSPLTQRE
WQVLGLIYSGYSNEQIAGELEVAATTIKTHIRNLYQKLGVAHRQDAVQHAQQLLKMMGYG
V

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Positively regulates the transcription of the maltose regulon whose gene products are responsible for uptake and catabolism of malto-oligosaccharides. Binds and recognizes a DNA motif (called the malT box):5'-GGA[TG]GA-3'

# Drug_Target_2_SwissProt_ID:
P06993

# Drug_Target_2_SwissProt_Name:
MALT_ECOLI

# Drug_Target_2_Synonyms:
ATP-dependent transcriptional activator malT

# Drug_Target_2_Theoretical_pI:
6.47

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X60998

# Drug_Target_3_GenBank_ID_Protein:
4377521

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
pptA

# Drug_Target_3_Gene_Sequence:
>234 bp
ATGCCGCACATCGACATTAAATGTTTTCCGCGTGAACTGGACGAACAACAAAAAGCAGCA
CTTGCTGCAGATATTACCGACGTTATTATTCGTCATCTGAACAGTAAAGACAGTTCGATA
AGCATTGCTCTACAGCAGATTCAACCAGAATCTTGGCAAGCTATCTGGGATGCCGAAATC
GCGCCCCAAATGGAGGCTTTGATAAAGAAACCTGGTTATAGCATGAATGCTTAA

# Drug_Target_3_General_Function:
Signal transduction mechanisms

# Drug_Target_3_General_References:
12356301	Almrud JJ, Kern AD, Wang SC, Czerwinski RM, Johnson WH Jr, Murzin AG, Hackert ML, Whitman CP: The crystal structure of YdcE, a 4-oxalocrotonate tautomerase homologue from Escherichia coli, confirms the structural basis for oligomer diversity. Biochemistry. 2002 Oct 8;41(40):12010-24.
8387990	Zhao S, Sandt CH, Feulner G, Vlazny DA, Gray JA, Hill CW: Rhs elements of Escherichia coli K-12: complex composites of shared and unique components that have different evolutionary histories. J Bacteriol. 1993 May;175(10):2799-808.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2958

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
8673

# Drug_Target_3_Name:
Probable tautomerase ydcE

# Drug_Target_3_Number_of_Residues:
77

# Drug_Target_3_PDB_ID:
1GYY

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01361	Tautomerase

# Drug_Target_3_Protein_Sequence:
>Probable tautomerase ydcE
MPHIDIKCFPRELDEQQKAALAADITDVIIRHLNSKDSSISIALQQIQPESWQAIWDAEI
APQMEALIKKPGYSMNA

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
P31992

# Drug_Target_3_SwissProt_Name:
PPTA_ECOLI

# Drug_Target_3_Synonyms:
EC 5.3.2.-

# Drug_Target_3_Theoretical_pI:
4.66

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Peroxisome

# Drug_Target_4_Chromosome_Location:
1

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X13227

# Drug_Target_4_GenBank_ID_Protein:
30446

# Drug_Target_4_GeneCard_ID:
DAO

# Drug_Target_4_Gene_Name:
DAO

# Drug_Target_4_Gene_Sequence:
>1044 bp
ATGCGTGTGGTGGTGATTGGAGCAGGAGTCATCGGGCTGTCCACCGCCCTCTGCATCCAT
GAGCGCTACCACTCAGTCCTGCAGCCACTGCACATAAAGGTCTACGCGGACCGCTTCACC
CCACTCACCACCACCGACGTGGCTGCCGGCCTCTGGCAGCCCTACCTTTCTGACCCCAAC
AACCCACAGGAGGCGGACTGGAGCCAACAGACCTTTGACTATCTCCTGAGCCATGTCCAT
TCTCCCAACGCTGAAAACCTGGGCCTGTTCCTAATCTCGGGCTACAACCTCTTCCATGAA
GCCATTCCGGACCCTTCCTGGAAGGACACAGTTCTGGGATTTCGGAAGCTGACCCCCAGA
GAGCTGGATATGTTCCCAGATTACGGCTATGGCTGGTTCCACACAAGCCTAATTCTGGAG
GGAAAGAACTATCTACAGTGGCTGACTGAAAGGTTAACTGAGAGGGGAGTGAAGTTCTTC
CAGCGGAAAGTGGAGTCTTTTGAGGAGGTGGCAAGAGAAGGCGCAGACGTGATTGTCAAC
TGCACTGGGGTATGGGCTGGGGCGCTACAACGAGACCCCCTGCTGCAGCCAGGCCGGGGG
CAGATCATGAAGGTGGACGCCCCTTGGATGAAGCACTTCATTCTCACCCATGACCCAGAG
AGAGGCATCTACAATTCCCCGTACATCATCCCAGGGACCCAGACAGTTACTCTTGGAGGC
ATCTTCCAGTTGGGAAACTGGAGTGAACTAAACAATATCCAGGACCACAACACCATTTGG
GAAGGCTGCTGCAGACTGGAGCCCACACTGAAGAATGCAAGAATTATTGGTGAAGCAACT
GGCTTCCGGCCAGTACGCCCCCAGATTCGGCTAGAAAGAGAACAGCTTCGCACTGGACCT
TCAAACACAGAGGTCATCCACAACTATGGCCATGGAGGCTACGGGCTCACCATCCACTGG
GGATGTGCCCTGGAGGCAGCCAAGCTCTTTGGGAGAATCCTGGAAGAAAAGAAATTGTCC
AGAATGCCACCATCCCACCTCTGA

# Drug_Target_4_General_Function:
Amino acid transport and metabolism

# Drug_Target_4_General_References:
1356107	Fukui K, Miyake Y: Molecular cloning and chromosomal localization of a human gene encoding D-amino-acid oxidase. J Biol Chem. 1992 Sep 15;267(26):18631-8.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
17088322	Kawazoe T, Tsuge H, Pilone MS, Fukui K: Crystal structure of human D-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci. 2006 Dec;15(12):2708-17. Epub 2006 Nov 6.
17303072	Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K: Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis. Biochem Biophys Res Commun. 2007 Apr 6;355(2):385-91. Epub 2007 Feb 8.
18455394	Sparey T, Abeywickrema P, Almond S, Brandon N, Byrne N, Campbell A, Hutson PH, Jacobson M, Jones B, Munshi S, Pascarella D, Pike A, Prasad GS, Sachs N, Sakatis M, Sardana V, Venkatraman S, Young MB: The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3386-91. Epub 2008 Apr 13.
2901986	Momoi K, Fukui K, Watanabe F, Miyake Y: Molecular cloning and sequence analysis of cDNA encoding human kidney D-amino acid oxidase. FEBS Lett. 1988 Sep 26;238(1):180-4.

# Drug_Target_4_HGNC_ID:
GNC:2671

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6645

# Drug_Target_4_Locus:
12q24

# Drug_Target_4_Molecular_Weight:
39473.7

# Drug_Target_4_Name:
D-amino-acid oxidase

# Drug_Target_4_Number_of_Residues:
347

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01266	DAO

# Drug_Target_4_Protein_Sequence:
>D-amino-acid oxidase
MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPN
NPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPR
ELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVN
CTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGG
IFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGP
SNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Regulates the level of the neuromodulator D-serine in the brain. Has high activity towards D-DOPA and contributes to dopamine synthesis. Could act as a detoxifying agent which removes D-amino acids accumulated during aging. Acts on a variety of D- amino acids with a preference for those having small hydrophobic side chains followed by those bearing polar, aromatic, and basic groups. Does not act on acidic amino acids

# Drug_Target_4_SwissProt_ID:
P14920

# Drug_Target_4_SwissProt_Name:
OXDA_HUMAN

# Drug_Target_4_Synonyms:
DAAO
DAMOX
DAO

# Drug_Target_4_Theoretical_pI:
6.84

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasm. Nucleus. Note=Mostly cytoplasmic but, in less differentiated cells occasionally nuclear

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
HRSP12

# Drug_Target_5_GenBank_ID_Gene:
X95384

# Drug_Target_5_GenBank_ID_Protein:
1177435

# Drug_Target_5_GeneCard_ID:
HRSP12

# Drug_Target_5_Gene_Name:
HRSP12

# Drug_Target_5_Gene_Sequence:
>414 bp
ATGTCGTCCTTGATCAGAAGGGTGATCAGCACCGCGAAAGCCCCAGGGGCCATTGGACCC
TACAGTCAAGCTGTATTAGTCGACAGGACCATTTACATTTCAGGACAGATAGGCATGGAC
CCTTCAAGTGGACAGCTTGTGTCAGGAGGGGTAGCAGAAGAAGCTAAACAAGCTCTTAAA
AACATGGGTGAAATTCTGAAAGCTGCAGGCTGTGACTTCACTAACGTGGTGAAAACAACT
GTTCTTCTGGCTGACATAAATGACTTCAATACTGTCAATGAAATCTACAAACAGTATTTC
AAGAGTAATTTTCCTGCTAGAGCTGCTTACCAAGTTGCTGCTTTACCCAAAGGCAGCCGA
ATTGAAATTGAAGCAGTAGCTATCCAAGGACCACTGACAACGGCATCACTATAA

# Drug_Target_5_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_5_General_References:
8973653	Schmiedeknecht G, Kerkhoff C, Orso E, Stohr J, Aslanidis C, Nagy GM, Knuechel R, Schmitz G: Isolation and characterization of a 14.5-kDa trichloroacetic-acid-soluble translational inhibitor protein from human monocytes that is upregulated upon cellular differentiation. Eur J Biochem. 1996 Dec 1;242(2):339-51.

# Drug_Target_5_HGNC_ID:
HGNC:16897

# Drug_Target_5_HPRD_ID:
03924

# Drug_Target_5_ID:
3014

# Drug_Target_5_Locus:
8q22

# Drug_Target_5_Molecular_Weight:
14494

# Drug_Target_5_Name:
Ribonuclease UK114

# Drug_Target_5_Number_of_Residues:
137

# Drug_Target_5_PDB_ID:
1ONI

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01042	Ribonuc_L-PSP

# Drug_Target_5_Protein_Sequence:
>Ribonuclease UK114
MSSLIRRVISTAKAPGAIGPYSQAVLVDRTIYISGQIGMDPSSGQLVSGGVAEEAKQALK
NMGEILKAAGCDFTNVVKTTVLLADINDFNTVNEIYKQYFKSNFPARAAYQVAALPKGSR
IEIEAVAIQGPLTTASL

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Endoribonuclease responsible for the inhibition of the translation by cleaving mRNA. Inhibits cell-free protein synthesis. Cleaves phosphodiester bonds only in single-stranded RNA

# Drug_Target_5_SwissProt_ID:
P52758

# Drug_Target_5_SwissProt_Name:
UK114_HUMAN

# Drug_Target_5_Synonyms:
14.5 kDa translational inhibitor protein
EC 3.1.-.-
UK114 antigen homolog
p14.5

# Drug_Target_5_Theoretical_pI:
9.01

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AF003948

# Drug_Target_6_GenBank_ID_Protein:
2935033

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
clcA

# Drug_Target_6_Gene_Sequence:
>774 bp
ATGGCCAATACACGCGTGATCGAGTTGTTCGACGAATTCACCGATCTCATCCGTGATTTC
ATCGTCCGTCACGAGATCACCACACCGGAGTACGAAACGATCATGCAATACATGATCAGC
GTCGGCGAGGCCGGCGAGTGGCCGCTGTGGCTCGACGCGTTCTTCGAAACCACCGTCGAC
TCCGTGAGCTACGGCAAGGGAAACTGGACCTCCAGTGCGATCCAAGGACCGTTCTTCAAA
GAAGGTGCCCCGCTGCTGACCGGCAAACCGGCCACCCTGCCGATGCGGGCAGACGAGCCT
GGCGACCGGATGCGGTTCACCGGGAGCGTGCGCGACACGTCGGGAACTCCGATCACCGGC
GCGGTCATCGATGTGTGGCACTCCACCAACGACGGCAACTACAGCTTTTTCTCCCCCGCT
CTGCCCGACCAGTACCTGCTGCGCGGCAGGGTCGTCCCCGCCGAAGACGGCAGCATCGAG
TTCCACAGCATCCGACCGGTGCCCTACGAAATCCCGAAAGCTGGCCCCACGGGCCAGCTC
ATGAACTCATACCTCGGCCGGCACTCCTGGCGCCCCGCACACATCCACATCCGCATCACC
GCCGACGGGTACCGGCCACTGATCACCCAGCTCTACTTCGAGGGCGACCCGTACCTGGAC
AGCGACTCCTGCTCGGCAGTCAAGAGCGAACTGGTTCTGCCGGTCAACAAGATCGACATC
GACGGCGAAACATGGCAGCTAGTCGACTTCAACTTCATTCTCCAGCACAACTGA

# Drug_Target_6_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_6_General_References:
9495745	Eulberg D, Kourbatova EM, Golovleva LA, Schlomann M: Evolutionary relationship between chlorocatechol catabolic enzymes from Rhodococcus opacus 1CP and their counterparts in proteobacteria: sequence divergence and functional convergence. J Bacteriol. 1998 Mar;180(5):1082-94.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
3603

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
28953

# Drug_Target_6_Name:
Chlorocatechol 1,2-dioxygenase

# Drug_Target_6_Number_of_Residues:
257

# Drug_Target_6_PDB_ID:
1S9A

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00775	Dioxygenase_C
PF04444	Dioxygenase_N

# Drug_Target_6_Protein_Sequence:
>Chlorocatechol 1,2-dioxygenase
MANTRVIELFDEFTDLIRDFIVRHEITTPEYETIMQYMISVGEAGEWPLWLDAFFETTVD
SVSYGKGNWTSSAIQGPFFKEGAPLLTGKPATLPMRADEPGDRMRFTGSVRDTSGTPITG
AVIDVWHSTNDGNYSFFSPALPDQYLLRGRVVPAEDGSIEFHSIRPVPYEIPKAGPTGQL
MNSYLGRHSWRPAHIHIRITADGYRPLITQLYFEGDPYLDSDSCSAVKSELVLPVNKIDI
DGETWQLVDFNFILQHN

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
4-chlorocatechol + O(2) = 3-chloro-muconate

# Drug_Target_6_SwissProt_ID:
O67987

# Drug_Target_6_SwissProt_Name:
CLCA_RHOOP

# Drug_Target_6_Synonyms:
EC 1.13.11.-

# Drug_Target_6_Theoretical_pI:
4.53

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cell membrane
cytoplasmic side (Potential)
lipid-anchor

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
RAB9

# Drug_Target_7_GenBank_ID_Gene:
U44103

# Drug_Target_7_GenBank_ID_Protein:
1174147

# Drug_Target_7_GeneCard_ID:
RAB9

# Drug_Target_7_Gene_Name:
RAB9A

# Drug_Target_7_Gene_Sequence:
>606 bp
ATGGCAGGAAAATCTTCACTTTTTAAAGTAATTCTCCTTGGAGATGGTGGAGTTGGGAAG
AGTTCACTTATGAACAGATATGTAACTAATAAGTTTGATACCCAGCTCTTCCATACAATA
GGTGTGGAATTTTTAAATAAAGATTTGGAAGTGGATGGACATTTTGTTACCATGCAGATT
TGGGACACGGCAGGTCAGGAGCGATTCCGAAGCCTGAGGACACCATTTTACAGAGGTTCT
GACTGCTGCCTGCTTACTTTTAGTGTCGATGATTCACAAAGCTTCCAGAACTTAAGTAAC
TGGAAGAAAGAATTCATATATTATGCAGATGTGAAAGAGCCTGAGAGCTTTCCTTTTGTG
ATTCTGGGTAACAAGATTGACATAAGCGAACGGCAGGTGTCTACAGAAGAAGCCCAAGCT
TGGTGCAGGGACAACGGCGACTATCCTTATTTTGAAACAAGTGCAAAAGATGCCACAAAT
GTGGCAGCAGCCTTTGAGGAAGCGGTTCGAAGAGTTCTTGCTACCGAGGATAGGTCAGAT
CATTTGATTCAGACAGACACAGTCAATCTTCACCGAAAGCCCAAGCCTAGCTCATCTTGC
TGTTGA

# Drug_Target_7_General_Function:
Involved in GTP binding

# Drug_Target_7_General_References:
9126495	Davies JP, Cotter PD, Ioannou YA: Cloning and mapping of human Rab7 and Rab9 cDNA sequences and identification of a Rab9 pseudogene. Genomics. 1997 Apr 1;41(1):131-4.

# Drug_Target_7_HGNC_ID:
HGNC:9792

# Drug_Target_7_HPRD_ID:
02236

# Drug_Target_7_ID:
3115

# Drug_Target_7_Locus:
Xp22.2

# Drug_Target_7_Molecular_Weight:
22838

# Drug_Target_7_Name:
Ras-related protein Rab-9

# Drug_Target_7_Number_of_Residues:
201

# Drug_Target_7_PDB_ID:
1WMS

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00071	Ras

# Drug_Target_7_Protein_Sequence:
>Ras-related protein Rab-9
MAGKSSLFKVILLGDGGVGKSSLMNRYVTNKFDTQLFHTIGVEFLNKDLEVDGHFVTMQI
WDTAGQERFRSLRTPFYRGSDCCLLTFSVDDSQSFQNLSNWKKEFIYYADVKEPESFPFV
ILGNKIDISERQVSTEEAQAWCRDNGDYPYFETSAKDATNVAAAFEEAVRRVLATEDRSD
HLIQTDTVNLHRKPKPSSSCC

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Involved in the transport of proteins between the endosomes and the trans Golgi network

# Drug_Target_7_SwissProt_ID:
P51151

# Drug_Target_7_SwissProt_Name:
RAB9A_HUMAN

# Drug_Target_7_Synonyms:
Rab-9A

# Drug_Target_7_Theoretical_pI:
5.10

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
D83955

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
cumD

# Drug_Target_8_Gene_Sequence:
>849 bp
ATGGCAAACCTGGAAATAGGTAAAAGTATTTTAGCTGCAGGGGTTCTAACAAACTATCAC
GATGTCGGGGAGGGACAGCCTGTGATACTAATTCATGGTTCTGGGCCCGGCGTGAGCGCT
TATGCGAATTGGCGACTGACCATTCCTGCTCTGAGCAAGTTTTATCGTGTTATCGCCCCT
GATATGGTTGGTTTTGGCTTTACGGATCGACCTGAAAACTATAATTATTCCAAGGATAGT
TGGGTTGACCATATAATCGGTATTATGGACGCCCTGGAAATAGAAAAGGCTCACATCGTA
GGTAACTCATTCGGTGGGGGGCTGGCGATTGCTACCGCGCTTCGTTATTCGGAGCGCGTT
GATCGTATGGTTCTGATGGGGGCGGCCGGTACTCGCTTTGACGTGACAGAGGGCCTGAAC
GCGGTGTGGGGTTACACGCCGTCGATAGAAAACATGCGTAATCTCCTCGATATATTCGCT
TATGATCGCTCCTTAGTCACCGACGAATTAGCGAGACTTCGATATGAGGCGAGTATTCAG
CCAGGATTTCAAGAGTCATTCTCCAGCATGTTTCCTGAGCCGCGCCAACGCTGGATAGAC
GCGTTGGCTAGCTCGGATGAAGATATCAAGACTCTTCCCAATGAGACACTGATTATTCAT
GGTCGAGAGGATCAGGTTGTTCCTCTATCCAGCAGTCTGCGTCTAGGCGAACTTATCGAC
CGGGCGCAGTTGCATGTTTTCGGGCGATGTGGGCACTGGACACAAATTGAGCAGACTGAC
CGATTCAATCGTCTTGTGGTCGAGTTTTTTAATGAGGCCAACACACCTAAACTAGTGGGT
CGTCCGTAA

# Drug_Target_8_General_Function:
Involved in hydrolase activity

# Drug_Target_8_General_References:
12192074	Fushinobu S, Saku T, Hidaka M, Jun SY, Nojiri H, Yamane H, Shoun H, Omori T, Wakagi T: Crystal structures of a meta-cleavage product hydrolase from Pseudomonas fluorescens IP01 (CumD) complexed with cleavage products. Protein Sci. 2002 Sep;11(9):2184-95.
8953719	Habe H, Kasuga K, Nojiri H, Yamane H, Omori T: Analysis of cumene (isopropylbenzene) degradation genes from Pseudomonas fluorescens IP01. Appl Environ Microbiol. 1996 Dec;62(12):4471-7.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
4674

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
31490

# Drug_Target_8_Name:
2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase

# Drug_Target_8_Number_of_Residues:
282

# Drug_Target_8_PDB_ID:
1UKB

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00561	Abhydrolase_1

# Drug_Target_8_Protein_Sequence:
>2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase
MANLEIGKSILAAGVLTNYHDVGEGQPVILIHGSGPGVSAYANWRLTIPALSKFYRVIAP
DMVGFGFTDRPENYNYSKDSWVDHIIGIMDALEIEKAHIVGNSFGGGLAIATALRYSERV
DRMVLMGAAGTRFDVTEGLNAVWGYTPSIENMRNLLDIFAYDRSLVTDELARLRYEASIQ
PGFQESFSSMFPEPRQRWIDALASSDEDIKTLPNETLIIHGREDQVVPLSSSLRLGELID
RAQLHVFGRCGHWTQIEQTDRFNRLVVEFFNEANTPKLVGRP

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
P96965

# Drug_Target_8_SwissProt_Name:
P96965_PSEFL

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
5.03

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasmic

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AF031242

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
cpo

# Drug_Target_9_Gene_Sequence:
>837 bp
ATGCCGTTCATCACCGTCGGCCAGGAGAACTCCACCTCCATCGACCTCTACTACGAGGAC
CACGGCGCTGGGCAGCCGGTCGTCCTCATCCACGGGTTCCCGCTGAGCGGGCACTCCTGG
GAGCGGCAGAGCGCCGCACTGCTCGACGCCGGCTACCGGGTCATCACCTACGACCGCCGC
GGTTTCGGCCAGTCCTCCCAGCCCACCACCGGCTACGACTACGACACCTTCGCCGCGGAC
CTCAACACCGTGCTGGAGACCCTCGACCTCCAGGACGCCGTGCTGGTCGGCTTCTCGATG
GGCACCGGCGAGGTCGCCCGGTACGTGTCCTCCTACGGCACCGCCCGCATCGCCAAGGTC
GCCTTCCTGGCCTCCCTGGAGCCGTTCCTGCTGAAGACCGACGACAACCCGGACGGCGCC
GCCCCGAAGGAGTTCTTCGACGGCATCGTCGCCGCCGTGAAGGCCGACCGGTACGCCTTC
TACACCGGCTTCTTCAACGACTTCTACAACCTGGACGAGAACCTCGGCACCCGGATCAGC
GAGGAGGCCGTCCGCAACAGCTGGAACACCGCGGCGAGCGGCGGCTTCTTCGCCGCCGCG
GCCGCGCCCACCACCTGGTACACCGACTTCCGCGCCGACATCCCCCGCATCGACGTCCCC
GCGCTGATCCTGCACGGCACCGGCGACCGCACCCTGCCCATCGAGAACACCGCCCGGGTC
TTCCACAAGGCGCTGCCCTCCGCCGAGTACGTGGAGGTCGAGGGCGCGCCGCACGGCCTG
CTCTGGACCCACGCCGAGGAAGTGAACACCGCGCTGCTCGCCTTCCTCGCGAAGTGA

# Drug_Target_9_General_Function:
Involved in hydrolase activity

# Drug_Target_9_General_References:
9642069	Hofmann B, Tolzer S, Pelletier I, Altenbuchner J, van Pee KH, Hecht HJ: Structural investigation of the cofactor-free chloroperoxidases. J Mol Biol. 1998 Jun 19;279(4):889-900.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
5426

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
30355

# Drug_Target_9_Name:
Non-heme chloroperoxidase

# Drug_Target_9_Number_of_Residues:
278

# Drug_Target_9_PDB_ID:
1A8U

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00561	Abhydrolase_1

# Drug_Target_9_Protein_Sequence:
>Non-heme chloroperoxidase
MPFITVGQENSTSIDLYYEDHGAGQPVVLIHGFPLSGHSWERQSAALLDAGYRVITYDRR
GFGQSSQPTTGYDYDTFAADLNTVLETLDLQDAVLVGFSMGTGEVARYVSSYGTARIAKV
AFLASLEPFLLKTDDNPDGAAPKEFFDGIVAAVKADRYAFYTGFFNDFYNLDENLGTRIS
EEAVRNSWNTAASGGFFAAAAAPTTWYTDFRADIPRIDVPALILHGTGDRTLPIENTARV
FHKALPSAEYVEVEGAPHGLLWTHAEEVNTALLAFLAK

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
2 RH + 2 Cl(-) + H(2)O(2) = 2 RCl + 2 H(2)O

# Drug_Target_9_SwissProt_ID:
O31168

# Drug_Target_9_SwissProt_Name:
PRXC_STRAU

# Drug_Target_9_Synonyms:
CPO-T
Chloride peroxidase
Chloroperoxidase T
EC 1.11.1.10

# Drug_Target_9_Theoretical_pI:
4.41

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03793
